REAL-WORLD EVIDENCE RECOMMENDATIONS FOR GENE THERAPIES: REGULATORY VERSUS HEALTH TECHNOLOGY ASSESSMENT

被引：0
|
作者：
Allen, G. [1 ]
Summers, D. M. [1 ]
Evans, J. [1 ]
机构：
[1] Costello Med, Cambridge, England
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PBI43
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [41] Should real-world evidence be incorporated into regulatory approvals?
    Spitzer, Ernest
    Cannon, Christopher P.
    Serruys, Patrick W.
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (12) : 1155 - 1159
  • [42] Examining the Use of Real-World Evidence in the Regulatory Process
    Beaulieu-Jones, Brett K.
    Finlayson, Samuel G.
    Yuan, William
    Altman, Russ B.
    Kohane, Isaac S.
    Prasad, Vinay
    Yu, Kun-Hsing
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (04) : 843 - 852
  • [43] Use of Real-World Evidence for Regulatory Approval and Coverage of Medical Devices: A Landscape Assessment
    Timbie, Justin W.
    Kim, Alice Y.
    Concannon, Thomas W.
    VALUE IN HEALTH, 2021, 24 (12) : 1792 - 1798
  • [44] SATURN: assessing the feasibility of utilising existing registries for real-world evidence data collection to meet patients, regulatory, health technology assessment and payer requirements
    Sangiorgi, L.
    Boarini, M.
    Mordenti, M.
    Wang, V.
    Westerheim, I.
    Skarberg, R. T.
    Cavaller-Bellaubi, M.
    Clancy, James
    Pinedo-Villanueva, R.
    Lente, E. J. V.
    Marchetti, M.
    ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
  • [45] Real-world evidence to support regulatory submissions: A landscape review and assessment of use cases
    Alipour-Haris, Golnoosh
    Liu, Xinyue
    Acha, Virginia
    Winterstein, Almut G.
    Burcu, Mehmet
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (08):
  • [46] Real-world evidence and nonrandomized data in health technology assessment: use existing methods to address unmeasured confounding?
    Sammon, Cormac J.
    Leahy, Thomas P.
    Gsteiger, Sandro
    Ramagopalan, Sreeram
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (14) : 969 - 972
  • [47] R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment
    Simpson, Alex
    Ramagopalan, Sreeram, V
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (10) : 797 - 799
  • [48] THE USE OF REAL-WORLD DATA IN HEALTH TECHNOLOGY ASSESSMENT OF MEDICATIONS FOR RARE DISEASES
    Harwood, M.
    Deighton, A.
    Mickle, A.
    Qian, C.
    Szabo, S.
    VALUE IN HEALTH, 2019, 22 : S863 - S863
  • [49] The (Harsh) Reality of Real-World Data External Comparators for Health Technology Assessment
    Cox, Oliver
    Sammon, Cormac
    Simpson, Alex
    Wasiak, Radek
    Ramagopalan, Sreeram
    Thorlund, Kristian
    VALUE IN HEALTH, 2022, 25 (07) : 1253 - 1256
  • [50] REAL-WORLD DATA TO SUPPORT SURROGATE ENDPOINT EVALUATION FOR HEALTH TECHNOLOGY ASSESSMENT
    Dupin, J.
    Thokagevistk, K.
    Emonnot, L.
    Micon, S.
    Benyounes, K.
    Haves, D.
    Civet, A.
    Pau, D.
    Le Dissez, C.
    Gally, S.
    Esnault, C.
    VALUE IN HEALTH, 2022, 25 (12) : S456 - S457
12345